Antiatherosclerotic effect of the ACAT inhibitor F 12511 in casein-fed New-Zealand rabbit (original) (raw)

ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia

Raphaël Duivenvoorden, Evan Stein

JAMA, 2009

View PDFchevron_right

ACAT inhibitors: evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents

Drug Discovery Today, 1998

View PDFchevron_right

Statin Therapy Alone and in Combination with an Acyl-CoA:Cholesterol O-Acyltransferase Inhibitor on Experimental Atherosclerosis

Pathophysiology of Haemostasis and Thrombosis, 2007

View PDFchevron_right

Update on the role of acyl-CoA:cholesterol acyltransferase inhibitors in atherosclerosis

Expert Opinion on Therapeutic Patents, 2001

View PDFchevron_right

Atorvastatin reduces blood serum cholesterol in Wistar rats fed a high cholesterol diet (undergraduate thesis paper)

View PDFchevron_right

ACAT Inhibition Reduces the Progression of Preexisting, Advanced Atherosclerotic Mouse Lesions Without Plaque or Systemic Toxicity

Arteriosclerosis, Thrombosis, and Vascular Biology, 2013

View PDFchevron_right

Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions

P. Lallier, Réda Ibrahim

Circulation, 2004

View PDFchevron_right

Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia

Atherosclerosis, 2003

View PDFchevron_right

Antiatherosclerotic agents. A structurally novel bivalent inhibitor of AcylCoA:cholesterol O-acyltransferase with systemic activity

Ronald B Gammill

Journal of Medicinal Chemistry, 1990

View PDFchevron_right

Effect of Atorvastatin on High-Density Lipoprotein Apolipoprotein A-I Production and Clearance in the New Zealand White Rabbit

Anthimos Pehlivanidis

Circulation, 2002

View PDFchevron_right

Effect of ACAT inhibition on the progression of coronary atherosclerosis

Paul Schoenhagen

… England Journal of …, 2006

View PDFchevron_right

Acyl-CoA:Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to Its Cholesterol-Lowering Effect in ApoE*3-Leiden Mice

2010

View PDFchevron_right

Potential Role of Acyl-Coenzyme A:Cholesterol Transferase (ACAT) Inhibitors as Hypolipidemic and Antiatherosclerosis Drugs

Pharmaceutical Research, 2005

View PDFchevron_right

Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology, 2005

View PDFchevron_right

Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin

Loukianos Rallidis

View PDFchevron_right

Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis

Acta biochimica et biophysica Sinica, 2006

View PDFchevron_right

H ypoc holesterolem ic act ions of atorvastat i n are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig

View PDFchevron_right

Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits

José-manuel Fragoso

International Journal of Molecular Sciences, 2019

View PDFchevron_right

Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [(18)F]FDG uptake in Ldlr(-/-)Apob(100/100) mice

Atherosclerosis, 2017

View PDFchevron_right

Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta

Bertrand Perret

Atherosclerosis, 1989

View PDFchevron_right

Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia

Atherosclerosis, 2000

View PDFchevron_right

A-002 (Varespladib), a phospholipase A2 inhibitor, reduces atherosclerosis in guinea pigs

BMC Cardiovascular Disorders, 2009

View PDFchevron_right

Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties

Steven Feinmark

British Journal of Pharmacology, 1997

View PDFchevron_right

Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism

The Journal of Lipid Research, 2007

View PDFchevron_right

LCAT cholesterol esterification is associated with the increase of ApoE/ApoA-I ratio during atherosclerosis progression in rabbit

Giovanni Di Salvo

Journal of Physiology and Biochemistry, 2012

View PDFchevron_right

The Antiatherosclerotic Effect of Anipamil in Cholesterol-Fed Rabbits

Alberico Catapano

Annals of the New York Academy of Sciences, 1988

View PDFchevron_right

Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2

Arteriosclerosis, Thrombosis, and Vascular Biology, 2008

View PDFchevron_right

l-Arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits

Christophe Moinard

British Journal of Nutrition, 2007

View PDFchevron_right

The therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced rabbit aortic atherosclerosis and stiffness

Hsueh-wen Chang

International journal of cardiology, 2017

View PDFchevron_right

Influence of the acyl-CoA:cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988

View PDFchevron_right